Singapore markets closed

Tandem Diabetes Care, Inc. (0M0F.L)

LSE - LSE Delayed Price. Currency in USD
Add to watchlist
20.69-0.13 (-0.64%)
At close: 03:39PM BST
Full screen
Previous close20.82
Bid0.00 x N/A
Ask0.00 x N/A
Day's range20.69 - 20.69
52-week range19.96 - 57.92
Avg. volume317
Market cap11.711M
Beta (5Y monthly)0.87
PE ratio (TTM)2.32
EPS (TTM)0.09
Earnings date31 Oct 2023 - 06 Nov 2023
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Motley Fool

    2 Stocks Under $25 to Buy and Hold for 10 Years

    The company's current lineup includes the t:slim X2 and the newly cleared Mobi Insulin Pump, which management calls "the world's smallest durable insulin delivery system." Despite this progress on the regulatory front, Tandem has been bruised and battered on the stock market over the past year, as its financial results haven't been as good. The company's sales of insulin pumps have declined amid the challenging economy, leading to lower year-over-year revenue growth.

  • Zacks

    Here's Why You Should Retain Tandem Diabetes (TNDM) Now

    Investors continue to be optimistic about Tandem Diabetes (TNDM) due to the t:slim X2 insulin pump and new product innovations.

  • Business Wire

    Tandem Diabetes Care Announces Upcoming Conference Presentations

    SAN DIEGO, August 24, 2023--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following investor conferences: